Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz
Shin Poong Pharm.Co.,Ltd. manufactures and sells pharmaceutical products in South Korea. It offers cardiovascular, anti-cancer, psychoneurotic, antirheumatic, antihistamine, and benign prostatic hyperplasia drugs, as well as antibiotics, antiulcerants, anti-diabetics, antifungal and antiviral agents, and trichogens. The company also provides NSAIDs, cardiovascular, anti-ulcer, respiratory, anti-diabetics, antibiotics, propulsive, anti-cancer, anti-arthritis, anti-spasmodic, and anti-helminthic active pharmaceutical ingredients (APIs). In addition, the company offers chemotherapeutics; hormones; contraceptive agents; vitamins and minerals; nutrition and dermatological products; eye, ear, and mouth preparations; and medical device anti-adhesion barriers, as well as neuro-muscular system, hematopoietic system, metabolism, alimentary system, respiratory system, genito-urinary system, and allergy and immune system APIs. It also exports its products to approximately 50 countries. Shin Poong Pharm.Co.,Ltd. was founded in 1962 and is based in Seoul, South Korea.
Shin Poong Pharm.Co.,Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.